Trial · NCT01572493
Results by group614
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 614
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximum Tolerated Dose (MTD) of Recombinant Human Interleukin-15 (rhIL-15) for 10 Day Dosing | All Participants | 2 | mcg/kg/day | ||
| Maximum Tolerated Dose (MTD) of Recombinant Human Interleukin-15 (rhIL-15) for 5 Day Dosing | All Participants | NA | mcg/kg/day | ||
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 1 - 0.1 mcg/kg/Day x 10 Days | Grade 3 | 2 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 2 - 0.25 mcg/kg/Day x 10 Days | Grade 3 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 3 - 0.5 mcg/kg/Day x 10 Days | Grade 3 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 4 - 1 mcg/kg/Day x 10 Days | Grade 3 | 1 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 5 - 2 mcg/kg/Day x 10 Days | Grade 3 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 6 - 4 mcg/kg/Day x 10 Days | Grade 3 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 7 - 3 mcg/kg/Day x 5 Days | Grade 3 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 8 - 4 mcg/kg/Day x 5 Days | Grade 3 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 9 - 5 mcg/kg/Day x 5 Days | Grade 3 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 1 - 0.1 mcg/kg/Day x 10 Days | Grade 4 | 2 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 2 - 0.25 mcg/kg/Day x 10 Days | Grade 4 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 3 - 0.5 mcg/kg/Day x 10 Days | Grade 4 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 4 - 1 mcg/kg/Day x 10 Days | Grade 4 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 5 - 2 mcg/kg/Day x 10 Days | Grade 4 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 6 - 4 mcg/kg/Day x 10 Days | Grade 4 | 1 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 7 - 3 mcg/kg/Day x 5 Days | Grade 4 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 8 - 4 mcg/kg/Day x 5 Days | Grade 4 | 0 | Participants | |
| Number of Participants With Grades 3, 4 or 5 Dose-Limiting Toxicity (DLT) Related to Study Drug | Dose Escalation Level 9 - 5 mcg/kg/Day x 5 Days | Grade 4 | 0 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01572493/results